Literature DB >> 25253946

Potential mechanisms of hepatitis B virus induced liver injury.

Mohd Suhail1, Hany Abdel-Hafiz1, Ashraf Ali1, Kaneez Fatima1, Ghazi A Damanhouri1, Esam Azhar1, Adeel Ga Chaudhary1, Ishtiaq Qadri1.   

Abstract

Chronic active hepatitis (CAH) is acknowledged as an imperative risk factor for the development of liver injury and hepatocellular carcinoma. The histological end points of CAH are chronic inflammation, fibrosis and cirrhosis which are coupled with increased DNA synthesis in cirrhotic vs healthy normal livers. The potential mechanism involved in CAH includes a combination of processes leading to liver cell necrosis, inflammation and cytokine production and liver scaring (fibrosis). The severity of liver damage is regulated by Hepatitis B virus genotypes and viral components. The viral and cellular factors that contribute to liver injury are discussed in this article. Liver injury caused by the viral infection affects many cellular processes such as cell signaling, apoptosis, transcription, DNA repair which in turn induce radical effects on cell survival, growth, transformation and maintenance. The consequence of such perturbations is resulted in the alteration of bile secretion, gluconeogenesis, glycolysis, detoxification and metabolism of carbohydrates, proteins, fat and balance of nutrients. The identification and elucidation of the molecular pathways perturbed by the viral proteins are important in order to design effective strategy to minimize and/or restore the hepatocytes injury.

Entities:  

Keywords:  Ground squirrel hepatitis virus; Hepatitis B virus; Hepatitis B virus genotype; Hepatocellular carcinoma; Interferon regulatory factor 7; Interleukin-1 receptor-associated kinase 4; Peripheral blood mononuclear cells; TNF receptor-associated factor 3; Woodchuck hepatitis virus

Mesh:

Substances:

Year:  2014        PMID: 25253946      PMCID: PMC4168079          DOI: 10.3748/wjg.v20.i35.12462

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  120 in total

Review 1.  Survival and apoptosis signals in ER stress: the role of protein kinases.

Authors:  Hisae Kadowaki; Hideki Nishitoh; Hidenori Ichijo
Journal:  J Chem Neuroanat       Date:  2004-09       Impact factor: 3.052

2.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

3.  The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake.

Authors:  Bei Yang; Michael J Bouchard
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

4.  Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.

Authors:  A Gramenzi; E Loggi; L Micco; C Cursaro; S Fiorino; S Galli; S Gitto; C Galli; G Furlini; M Bernardi; P Andreone
Journal:  J Viral Hepat       Date:  2011-06-01       Impact factor: 3.728

5.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

Authors:  Julie Lucifora; Silke Arzberger; David Durantel; Laura Belloni; Michel Strubin; Massimo Levrero; Fabien Zoulim; Olivier Hantz; Ulrike Protzer
Journal:  J Hepatol       Date:  2011-03-02       Impact factor: 25.083

6.  Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis.

Authors:  Michael C Kew
Journal:  World J Hepatol       Date:  2010-02-27

Review 7.  Effects of hepatitis B virus X protein on the development of liver cancer.

Authors:  Xiaodong Zhang; Hang Zhang; Lihong Ye
Journal:  J Lab Clin Med       Date:  2006-02

8.  Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment.

Authors:  Jianhua Li; Yinghui Liu; Zekun Wang; Kuancheng Liu; Yaohui Wang; Jiangxia Liu; Huanping Ding; Zhenghong Yuan
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

9.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Authors:  Qingqing Ding; Weiya Xia; Jaw-Ching Liu; Jer-Yen Yang; Dung-Fang Lee; Jiahong Xia; Geoffrey Bartholomeusz; Yan Li; Yong Pan; Zheng Li; Ralf C Bargou; Jun Qin; Chien-Chen Lai; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

10.  Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Authors:  Renate G van der Molen; Dave Sprengers; Rekha S Binda; Esther C de Jong; Hubert G M Niesters; Johannes G Kusters; Jaap Kwekkeboom; Harry L A Janssen
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

View more
  19 in total

Review 1.  Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Authors:  Danielle J Smalls; Reagan E Kiger; LeAnn B Norris; Charles L Bennett; Bryan L Love
Journal:  Pharmacotherapy       Date:  2019-11-03       Impact factor: 4.705

Review 2.  Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.

Authors:  Venessa Pattullo
Journal:  World J Hepatol       Date:  2015-05-08

3.  Current and Future Management of Chronic Hepatitis D.

Authors:  Patrizia Farci; Grazia Anna Niro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-06

4.  Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner.

Authors:  Yang-Xia Li; Yan-Li Ren; Hai-Jing Fu; Ling Zou; Ying Yang; Zhi Chen
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

5.  Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infection.

Authors:  Di Liu; Lin Liu; Lizheng Wang; Sizhu Duan; Yanan Song; Meng Qu; Nan Gao; Jiaxin Wu; Haihong Zhang; Hui Wu; Wei Kong; Bin Yu; Xianghui Yu
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

6.  Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory response.

Authors:  Hanchen Xu; Lei Wang; Peiyong Zheng; Yang Liu; Chunlei Zhang; Kaiping Jiang; Haiyan Song; Guang Ji
Journal:  Oncotarget       Date:  2017-06-13

7.  Prevalence of metabolic syndrome among adults with liver function injury in rural area of Southwest China: A cross-sectional study.

Authors:  Hui Zeng; Hui Lin; Wenyi Liu; Jia Wang; Lingqiao Wang; Chuanfen Zheng; Yao Tan; Yujing Huang; Lixiong He; Jiaohua Luo; Chaowen Pu; Renping Zhang; Xiaohong Yang; Yingqiao Tian; Zhiqun Qiu; Ji-An Chen; Yang Luo; Xiaobin Feng; Guosheng Xiao; Liping Wu; Weiqun Shu
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

8.  Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL.

Authors:  Virginie Nägele; Andrea Kratzer; Gerhard Zugmaier; Chris Holland; Youssef Hijazi; Max S Topp; Nicola Gökbuget; Patrick A Baeuerle; Peter Kufer; Andreas Wolf; Matthias Klinger
Journal:  Exp Hematol Oncol       Date:  2017-05-18

Review 9.  HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies.

Authors:  Xing Cao; Yafei Wang; Panyun Li; Wei Huang; Xiaojuan Lu; Hongda Lu
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

Review 10.  Mechanisms of liver disease in patients infected with HIV.

Authors:  Matthew B Kaspar; Richard K Sterling
Journal:  BMJ Open Gastroenterol       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.